 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- | MSV-allo / Citospin
Trial completion date, Trial primary completion date: MSV_LE: Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells (clinicaltrials.gov) - Apr 9, 2024
P2, N=20, Recruiting, Sponsor: Red de Terapia Celular
Trial completion date: Jul 2025 --> Jul 2026 | Trial primary completion date: Jul 2024 --> Jul 2025
- || MSV-allo / Citospin
Enrollment open: MSV_LE: Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells (clinicaltrials.gov) - Apr 4, 2023
P2, N=20, Recruiting, Sponsor: Red de Terapia Celular
Trial completion date: Jul 2025 --> Jul 2026 | Trial primary completion date: Jul 2024 --> Jul 2025 Not yet recruiting --> Recruiting
- ||| MSV-allo / Citospin
Enrollment change, Trial completion date, Trial primary completion date: MSV_LE: Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells (clinicaltrials.gov) - Dec 21, 2022
P2, N=20, Not yet recruiting, Sponsor: Red de Terapia Celular
Not yet recruiting --> Recruiting N=36 --> 20 | Trial completion date: Jun 2024 --> Jul 2025 | Trial primary completion date: Dec 2023 --> Jul 2024
- | MSV-allo / Citospin
Trial completion date, Trial primary completion date: MSV_LE: Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells (clinicaltrials.gov) - Jun 7, 2022
P2, N=36, Not yet recruiting, Sponsor: Red de Terapia Celular
N=36 --> 20 | Trial completion date: Jun 2024 --> Jul 2025 | Trial primary completion date: Dec 2023 --> Jul 2024 Trial completion date: Dec 2023 --> Jun 2024 | Trial primary completion date: Mar 2023 --> Dec 2023
- || MSV-allo / Citospin
Trial completion, Stroma: COVID_MSV: Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells (clinicaltrials.gov) - Jun 7, 2022
P2, N=24, Completed, Sponsor: Red de Terapia Celular
Trial completion date: Dec 2023 --> Jun 2024 | Trial primary completion date: Mar 2023 --> Dec 2023 Recruiting --> Completed
- | MSV-allo / Citospin
Trial completion date, Trial primary completion date: MSV_LE: Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells (clinicaltrials.gov) - Sep 23, 2021
P2, N=36, Not yet recruiting, Sponsor: Red de Terapia Celular
Recruiting --> Completed Trial completion date: Dec 2021 --> Dec 2023 | Trial primary completion date: Dec 2021 --> Mar 2023
- | MSV-allo / Citospin
Trial completion date, Trial primary completion date, Stroma: COVID_MSV: Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells (clinicaltrials.gov) - Mar 10, 2021
P2, N=24, Recruiting, Sponsor: Red de Terapia Celular
Trial completion date: Dec 2021 --> Dec 2023 | Trial primary completion date: Dec 2021 --> Mar 2023 Trial completion date: Dec 2020 --> Dec 2021 | Trial primary completion date: Nov 2020 --> Nov 2021
- || MSV-allo / Citospin
Enrollment open, Stroma: COVID_MSV: Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells (clinicaltrials.gov) - Apr 28, 2020
P2, N=24, Recruiting, Sponsor: Red de Terapia Celular
Trial completion date: Dec 2020 --> Dec 2021 | Trial primary completion date: Nov 2020 --> Nov 2021 Not yet recruiting --> Recruiting
- || MSV-allo / Citospin
New P2 trial, Stroma: COVID_MSV: Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells (clinicaltrials.gov) - Apr 23, 2020
P2, N=24, Not yet recruiting, Sponsor: Red de Terapia Celular
- | MSV-allo / Citospin
New P2 trial: MSV_LE: Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells (clinicaltrials.gov) - Sep 17, 2018
P2, N=36, Not yet recruiting, Sponsor: Red de Terapia Celular
- | MSV-allo / Citospin
Trial completion, Trial primary completion date, Stroma: Disc_allo: Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV) (clinicaltrials.gov) - Apr 26, 2017
P1/2, N=25, Completed, Sponsor: Red de Terapia Celular
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Apr 2017
- MSV-allo / Citospin
Trial primary completion date, Stroma: Disc_allo: Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV) (clinicaltrials.gov) - Oct 11, 2016
P1/2, N=24, Active, not recruiting, Sponsor: Red de Terapia Celular
Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Apr 2017 Trial primary completion date: Jul 2016 --> Dec 2016
- MSV-allo / Citospin
Trial primary completion date, Stroma: Disc_allo: Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV) (clinicaltrials.gov) - Apr 7, 2016
P1/2, N=24, Active, not recruiting, Sponsor: Red de Terapia Celular
Trial primary completion date: Jul 2016 --> Dec 2016 Trial primary completion date: Dec 2015 --> Jul 2016
- MSV-allo / Citospin
Trial primary completion date, Stroma: Disc_allo: Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV) (clinicaltrials.gov) - Sep 29, 2015
P1/2, N=24, Active, not recruiting, Sponsor: Red de Terapia Celular
Trial primary completion date: Dec 2015 --> Jul 2016 Trial primary completion date: Jun 2015 --> Dec 2015
- MSV-allo / Citospin
Trial primary completion date, Stroma: Disc_allo: Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV) (clinicaltrials.gov) - May 5, 2015
P1/2, N=24, Active, not recruiting, Sponsor: Red de Terapia Celular
Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: Sep 2014 --> Jun 2015
- | MSV-allo / Citospin
Enrollment closed, Stroma: Disc_allo: Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV) (clinicaltrials.gov) - Jun 24, 2014
P1/2, N=24, Active, not recruiting, Sponsor: Red de Terapia Celular
Trial primary completion date: Sep 2014 --> Jun 2015 Recruiting --> Active, not recruiting
- | MSV-allo / Citospin
New P1/2 trial, Stroma: Disc_allo: Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV) (clinicaltrials.gov) - May 20, 2013
P1/2, N=24, Recruiting, Sponsor: Red de Terapia Celular